VPC

Vestal Point Capital Portfolio holdings

AUM $1.9B
This Quarter Return
-2.24%
1 Year Return
-12.28%
3 Year Return
5 Year Return
10 Year Return
AUM
$1.69B
AUM Growth
+$1.69B
Cap. Flow
+$495M
Cap. Flow %
29.37%
Top 10 Hldgs %
42.19%
Holding
93
New
24
Increased
32
Reduced
12
Closed
18
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARDX icon
76
Ardelyx
ARDX
$1.57B
-500,000
Closed -$3.45M
AVDL
77
Avadel Pharmaceuticals
AVDL
$1.42B
0
BDX icon
78
Becton Dickinson
BDX
$54.3B
-30,000
Closed -$7.23M
BHVN icon
79
Biohaven
BHVN
$1.71B
0
BMY icon
80
Bristol-Myers Squibb
BMY
$96.7B
-250,000
Closed -$12.9M
BRKR icon
81
Bruker
BRKR
$4.45B
-125,000
Closed -$8.63M
CRNX icon
82
Crinetics Pharmaceuticals
CRNX
$3.26B
-205,000
Closed -$10.5M
EW icon
83
Edwards Lifesciences
EW
$47.7B
-275,000
Closed -$18.1M
GILD icon
84
Gilead Sciences
GILD
$140B
-200,000
Closed -$16.8M
JANX icon
85
Janux Therapeutics
JANX
$1.38B
-485,000
Closed -$22M
PEN icon
86
Penumbra
PEN
$10.5B
-15,000
Closed -$2.91M
PRME icon
87
Prime Medicine
PRME
$595M
-1,070,000
Closed -$4.14M
PTCT icon
88
PTC Therapeutics
PTCT
$4.41B
-80,000
Closed -$2.97M
RLMD icon
89
Relmada Therapeutics
RLMD
$48.8M
-490,000
Closed -$1.59M
TARS icon
90
Tarsus Pharmaceuticals
TARS
$2.44B
-230,000
Closed -$7.56M
ZVRA icon
91
Zevra Therapeutics
ZVRA
$501M
-525,000
Closed -$3.64M
ITCI
92
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-30,000
Closed -$2.2M
NARI
93
DELISTED
Inari Medical, Inc. Common Stock
NARI
-1,550,000
Closed -$63.9M